Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.29 USD | -0.90% |
|
-1.50% | -24.89% |
09/05 | Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.89% | 8.45Cr | |
+7.39% | 7.21TCr | |
+15.93% | 904.53Cr | |
-22.81% | 440.44Cr | |
+17.59% | 439.23Cr | |
+25.93% | 393.64Cr | |
+4.64% | 210Cr | |
+9.09% | 197.11Cr | |
-36.86% | 187.45Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- ETON Stock
- News Eton Pharmaceuticals, Inc.
- HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating